实验性自身免疫性脑脊髓炎
小胶质细胞
炎症
免疫学
传出细胞增多
免疫系统
信号转导
Toll样受体
化学
细胞生物学
受体
癌症研究
吞噬作用
脑脊髓炎
自身免疫性疾病
调解人
多发性硬化
自身免疫
促炎细胞因子
生物
医学
先天免疫系统
神经炎症
作者
Yejin Lee,Hangyeol Park,Seongwon Pak,Misu Kim,Keunwook Lee
标识
DOI:10.3390/ijms272210132
摘要
Toll-like receptor (TLR) signaling contributes to inflammatory activation during autoimmune neuroinflammation. We previously demonstrated that a cell-penetrating TLR inhibitory peptide (cpTLR-i), designed to interfere with TLR adaptor recruitment, alleviated experimental colitis through functional modulation of macrophages. Here, we investigated the therapeutic and immunomodulatory effects of cpTLR-i in experimental autoimmune encephalomyelitis (EAE). cpTLR-i suppressed inflammatory mediator production in activated BV2 microglia while preserving MHC class II expression. Systemic cpTLR-i treatment delayed EAE onset, reduced disease severity, and attenuated CNS inflammation and demyelination. Immune profiling revealed reduced granulocyte accumulation and type 1 CD4+ T cells, increased FoxP3+ regulatory T cells, and functional reprogramming of microglia and infiltrating macrophages. Notably, cpTLR-i enhanced apoptotic-cell uptake by microglia and macrophages in vitro and induced an efferocytosis-associated program characterized by increased LXRα and CD36 expression even in the absence of exogenous TLR ligands. Pharmacological inhibition further implicated LXR signaling in this response, while cpTLR-i altered SOCS/STAT3 signaling, revealing an unexpected association between modulation of TLR signaling and signaling networks involved in the regulation of efferocytosis. These findings demonstrate that cpTLR-i not only suppresses inflammatory responses but also promotes pro-resolving functions of microglia and macrophages, suggesting that selective modulation of TLR signaling represents a potential therapeutic strategy for neuroinflammatory diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI